Invention Grant
US08957041B2 Short interfering ribonucleic acid (siRNA) for oral administration
有权
用于口服给药的短干扰核糖核酸（siRNA）
- Patent Title: Short interfering ribonucleic acid (siRNA) for oral administration
- Patent Title (中): 用于口服给药的短干扰核糖核酸（siRNA）
-
Application No.: US13651808Application Date: 2012-10-15
-
Publication No.: US08957041B2Publication Date: 2015-02-17
- Inventor: Francois Jean-Charles Natt , Eric Billy , Juerg Hunziker , Christian Rene Schnell
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Frank Wu
- Priority: GB0608838.9 20060504
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C07H21/04 ; C12N15/113
Abstract:
Short interfering ribonucleic acid (siRNA) for oral administration, said siRNA comprising two separate RNA strands that are complementary to each other over at least 15 nucleotides, wherein each strand is 49 nucleotides or less, and wherein at least one of which strands contains at least one chemical modification.
Public/Granted literature
- US20130230923A1 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration Public/Granted day:2013-09-05
Information query
IPC分类:
